Table 1.
Agonist | Inhibitor (concentration) | pD2 | Emax at 10 μM (% maximal carbachol) | n | |
---|---|---|---|---|---|
NKA | — | — | 7.2±0.2 | 98.8±12.0 | 12 |
[Lys5,MeLeu9,Nle10]NKA(4–10) | — | — | 7.9±0.1 | 105.2±5.0 | 6 |
NKA | TTX | 1 μM | 7.8±0.1 | 95.1±4.5 | 8 |
NKA | Indomethacin | 1 μM | 7.8±0.1 | 108.0±4.7 | 8 |
NKA | SR140333 | 1 μM | 7.5±0.2 | 97.6±5.2 | 5 |
1 nM | 6.6±0.3 | 94.2±7.7 | 5 | ||
NKA | SR48968 | 3 nM | 5.9±0.2** | 72.8±11.7 | 6 |
10 nM | 5.5±0.4** | 36.8±11.0** | 4 |
Abbreviations: NKA, neurokinin A; TTX, tetrodotoxin.
**P<0.01 (ANOVA followed by Dunnett's test).